Sector: Pharmaceuticals & Biotechnology

Small Cap

JFL Life Sciences Share Price

Q: What is the Market Capitalization of JFL Life Sciences Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 2 June 2025, the market cap for JFL Life Sciences Ltd. is approximately ₹ 34.3 Cr.

Q: What are the PE and PB ratios for JFL Life Sciences Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for JFL Life Sciences Ltd. is 8.3, and the Price-to-Book (PB) ratio is 0.8.

Q: What is the 52-Week High and Low for JFL Life Sciences Ltd.?

Over the past 52 weeks, the highest price reached by JFL Life Sciences Ltd. shares was ₹ 22.2, and the lowest price was ₹ 10.

Q: Who are the major shareholders of JFL Life Sciences Ltd.?

Significant shareholdings in JFL Life Sciences Ltd. typically include entities such as: Promoter Public Other Institutions (Note: Shareholding patterns can change; this represents major holders based on recent filings).

Q: Who are the peers of JFL Life Sciences Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, JFL Life Sciences Ltd. is often compared with other major players such as Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs, Corona Remedies, Sudeep Pharma and Curis Lifesciences for analysis and benchmarking.

JFL Life Sciences Ltd.

₹10.40

0.00(0.00%)

Trade Now

23rd Feb 2026 | 9:20 AM

NSE : JFLLIFE

Open Free Demat Account

JFL Life Sciences Performance

Price Movement

₹10.40

₹10.75

↘ Today's Low↗ Today's High

1 Year Performance

₹10.40

₹10.00

₹22.20

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹10.75

Low₹10.40

Open at₹10.75

Prev Close₹10.40

Volumes12.00 K

Avg Price₹10.57

Lower Circuit₹9.90

Upper Circuit₹10.90

Historical Performance

3M High₹15.40

3M Low₹10.00

1 Yr High₹22.20

1 Yr Low₹10.00

3 Yr High₹37.15

3 Yr Low₹10.00

5 Yr High₹37.15

5 Yr Low₹10.00

JFL Life Sciences Fundamentals

Market Cap

Low in industry

34.30 Cr.

PE Ratio (TTM)

Low in industry

8.30

Dividend Yield

Net Profit TTM

17% decr over last year

4.82

Net Profit Growth

17% decr over last year

4.82

PEG Ratio

Negative PEG TTM

-0.50

ROE

13.5% incr over last year

10.54

Operating Revenue TTM

80.06

Operating Revenue Growth

12% decr over last year

Book Value

Low in industry

0.80

MFI

MFI Overbought

72.17

RSI

RSI is mid-range

40.93

EPS (TTM)

Debt to Equity

Face Value

Operating Profit Margin Qtr.

Operating Profit Qtr.

Net Profit Qtr.

Operating Revenue Qtr.

PB Ratio

0.80

JFL Life Sciences Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Revenue	26.84	29.91	11.59	11.73	21.25
Operating Expense	23.49	26.99	9.65	10.36	19.91
Operating Profit	3.35	2.92	1.93	1.38	1.34
Depreciation	0.27	0.27	0.26	0.36	0.16
Interest	0.38	0.44	0.24	0.33	0.20
Tax	0.69	0.24	0.68	0.61	0.25
Net Profit	2.02	1.97	0.75	0.08	0.74

JFL Life Sciences Technicals

JFL Life Sciences Ltd. EMA & SMA

₹10.40

0.00 (0.00%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹11

Day EMA10 ₹11

Day EMA12 ₹11

Day EMA20 ₹11.2

Day EMA26 ₹11.2

Day EMA50 ₹11.7

Day EMA100 ₹12.7

Day EMA200 ₹14.4

JFL Life Sciences Support and Resistance

Resistance

First Resistance₹10.40

Second Resistance₹10.40

Third Resistance₹10.40

Support

First Support₹10.40

Second Support₹10.40

Third Support₹10.40

Technical Indicators

Day RSI40.93

Day MFI72.17

Day ADX21.04

Day Commodity Channel Index-101.00

William-86.49

Day MACD-0.20

Day MACD Signal Line-0.25

Day ATR0.44

Day ROC125-38.28

Day ROC21-8.37

JFL Life Sciences Shareholding Pattern

Held By	Sep 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoter	67.5	67.5	67.5	67.5	67.5
FII	0	0	0	0	0
DII	0	0	0	0	0
Public	32.5	32.5	32.5	32.5	32.5

JFL Life Sciences Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	12 K	12 K	100.00%
Week	12 K	12 K	100.00%
1 Month	20.8 K	20.8 K	100.00%
6 Month	19.76 K	24.05 K	82.18%

JFL Life Sciences SWOT Analysis

Strengths12

Weakness9

Opportunity0

Threats0

Buy Zone: Stocks in the buy zone based on days traded at current PE and P/BV

Profit making Companies with High ROCE and Low PE

PEG lower than Industry PEG

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Increasing profits every quarter for the past 3 quarters

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Annual Net Profits improving for last 2 years

Companies with Zero Promoter Pledge

Stock with Low PE (PE < = 10)

JFL Life Sciences Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
No Record Found

JFL Life Sciences Stock Comparison

Financials	Vivimed Labs Ltd.	Curis Lifesciences Ltd.	Amanta Healthcare Ltd.	Anlon Healthcare Ltd.	Medistep Healthcare Ltd.	Influx Healthtech Ltd.
Price (₹)	₹8.43	₹96.65	₹104	₹115.35	₹22.60	₹208
% Change	4.98%	-2.37%	-1.38%	-3.98%	4.87%	-3.26%
Revenue TTM (₹ Cr)	₹104.12	-	₹282.74	-	-	-
Net Profit TTM (₹ Cr)	₹-24.37	-	₹15.30	-	-	-
PE TTM	-2.90	12.80	26.50	-	7.70	36.10
1 Year Return	743	-24.49	-17.19	27.77	-47.44	117.34
ROCE	-5.63	-	-	-	-	-

Similar Stocks

MEDIORG

Medicamen Organics Ltd.

₹ 25.00

-1.96%

AMRUTANJAN

Amrutanjan Health Care Ltd.

₹ 604.00

-1.99%

SENORES

Senores Pharmaceuticals Ltd.

₹ 791.10

-2.37%

INNOVACAP

Innova Captab Ltd.

₹ 690.00

+3.06%

VALIANTLAB

Valiant Laboratories Ltd.

₹ 59.10

+1.37%

SIGACHI

Sigachi Industries Ltd.

₹ 21.22

-3.68%

WINDLAS

Windlas Biotech Ltd.

₹ 774.00

-0.82%

VINEETLAB

Vineet Laboratories Ltd.

₹ 31.51

-1.62%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 472.60

+0.23%

ZIMLAB

Zim Laboratories Ltd.

₹ 72.00

+1.72%

MEDICO

Medico Remedies Ltd.

₹ 48.00

+4.53%

DCAL

Dishman Carbogen Amcis Ltd.

₹ 182.40

+0.07%

LASA

Lasa Supergenerics Ltd.

₹ 8.05

+2.42%

ADVENZYMES

Advanced Enzyme Technologies Ltd.

₹ 313.00

+0.02%

BAJAJHCARE

Bajaj Healthcare Ltd.

₹ 348.00

-1.29%

ORTINGLOBE

Ortin Global Ltd.

₹ 18.91

-4.97%

BROOKS

Brooks Laboratories Ltd.

₹ 72.62

-2.48%

RPGLIFE

RPG Life Sciences Ltd.

₹ 1915.00

+0.59%

BAFNAPH

Bafna Pharmaceuticals Ltd.

₹ 111.50

-1.11%

ALPA

Alpa Laboratories Ltd.

₹ 68.45

+2.30%

SPARC

Sun Pharma Advanced Research Company Ltd.

₹ 127.75

-1.13%

SMSPHARMA

SMS Pharmaceuticals Ltd.

₹ 375.20

+0.74%

NECLIFE

Nectar Lifesciences Ltd.

₹ 12.70

+0.63%

MANGALAM

Mangalam Drugs and Organics Ltd.

₹ 31.15

-1.61%

FAQ's on JFLLIFE

What is the Market Capitalization of JFL Life Sciences Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 2 June 2025, the market cap for JFL Life Sciences Ltd. is approximately ₹ 34.3 Cr.

What are the PE and PB ratios for JFL Life Sciences Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for JFL Life Sciences Ltd. is 8.3, and the Price-to-Book (PB) ratio is 0.8.

What is the 52-Week High and Low for JFL Life Sciences Ltd.?

Over the past 52 weeks, the highest price reached by JFL Life Sciences Ltd. shares was ₹ 22.2, and the lowest price was ₹ 10.

Who are the major shareholders of JFL Life Sciences Ltd.?

Significant shareholdings in JFL Life Sciences Ltd. typically include entities such as:

Promoter
Public
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of JFL Life Sciences Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, JFL Life Sciences Ltd. is often compared with other major players such as Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs, Corona Remedies, Sudeep Pharma and Curis Lifesciences for analysis and benchmarking.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy